US$ 22.46
glp 1 agonists and inflammation GLP-1 drugs calm beyond diabetes weight loss GLP1 receptor agonists are supported
Description
Acta pharmacologica Sinica
2016;167(3):843-857.e814

the AACE guidelines and the European Society of Cardiology (ESC)/EASD guidelines also recommend GLP1RAs for these patients irrespective of glycaemic control

GLP-1 receptor agonists have been shown in multiple studies to exert anti-inflammatory effects, including inhibition of monocyte chemotaxis, suppression of macrophage inflammatory responses, and AMPK-mediated downregulation of the NF-B signaling pathway, thereby reducing systemic inflammation (36)
Nauck MA, Stockmanne F, Ebert R, Creutzfeldt W
